Time: February 5, 2014 from 1pm to 2pm
Location: Online Webinar - Eastern Time Zone
Website or Map: http://www.readytalk.com/
Phone: 866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Nov 14, 2014
Export to Outlook or iCal (.ics)
On February 5, 2014, Dr. Robert Spiegel, Chief Medical Officer at PTC Therapeutics, presented an update about PTC’s Phase 3 study of ataluren, now known as the Ataluren Confirmatory Trial in DMD (ACT DMD).
Comment
Hi Steven - We'll have the recording up early next week.
Hi, is there a recording of the webinar? If not, anyone got any feedback? Thanks.
Hopeful
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
RSVP for Webinar: ACT DMD Update with PTC to add comments!
Join PPMD Community